21
Symposium for Patients & Caregivers

Symposium for Patients & Caregivers

Embed Size (px)

DESCRIPTION

Symposium for Patients & Caregivers. Endoscopic and Combined Surgical Approaches. Ruth E. Bristol, MD Assistant Professor of Neurosurgery. Acknowledgements. Maggie Bobrowitz, RN, MBA HH team Harold Rekate, MD Adib Abla , MD Patients and Families. Outline. - PowerPoint PPT Presentation

Citation preview

Page 1: Symposium for Patients  & Caregivers

Symposium for Patients & Caregivers

Page 2: Symposium for Patients  & Caregivers

Endoscopic and Combined Surgical Approaches

Ruth E. Bristol, MD

Assistant Professor of Neurosurgery

Page 3: Symposium for Patients  & Caregivers

Acknowledgements

• Maggie Bobrowitz, RN, MBA• HH team• Harold Rekate, MD• Adib Abla, MD• Patients and Families

Page 4: Symposium for Patients  & Caregivers

Outline

• How do we choose the right surgery?• What does “endoscopic” mean?

• How an endoscope works• Choosing the endoscopic approach

• What does “combined” mean?• Why do we need a combined approach

Page 5: Symposium for Patients  & Caregivers

How Do We Get There?

Blow up of lesion

Page 6: Symposium for Patients  & Caregivers

Patient Selection

• Type II, III, and IV: Endoscopic +

• Type III and IV: Combined

Page 7: Symposium for Patients  & Caregivers

Risks of Treatment

• Memory loss

• Hypothalamic injury• Increased appetite• Diabetes inispidus• Other hormonal abnormalities

• Cranial nerve/ vascular injuries

Page 8: Symposium for Patients  & Caregivers

Risk Spectrum

• Lowest Risk

• Highest Risk

• Gamma Knife

• Endoscopic

• Transcallosal

• Orbitozygomatic

Page 9: Symposium for Patients  & Caregivers

What Is An Endoscope?

Page 10: Symposium for Patients  & Caregivers

Endoscopy

• Endoscope approaching lesion from side contralateral to attachment.

• Micromanipulator on the endoscope, and stereotactic guidance frame.

Page 11: Symposium for Patients  & Caregivers

Terms

• Contralateral• Ipsilateral

Page 12: Symposium for Patients  & Caregivers

Endoscopic

• Pros• Comparable seizure

control (49% vs 54%)• Shorter length of stays

(4.1 vs 7.7 days)

• Cons• Short term memory

loss• Less working room

(bad for large lesions)• Thalamic infarct

reported (~85 % asymptomatic)

Page 13: Symposium for Patients  & Caregivers

Endoscopic

• Background

Page 14: Symposium for Patients  & Caregivers

Surgery From Above

• Endoscopic series• 37 patients with seizures refractory to 3+ AED’s (32/37 started as gelastic)• Mean age of onset approx 10 months of age• 62 % with IQ < 70• Always a contralateral approach

• Preferred when attached to one ventricle• Results

Ng, Rekate et al. Neurology 2008

Page 15: Symposium for Patients  & Caregivers

Surgery From Above

• Percent of disconnect/resection (measured by blinded radiologist)• Not statistically tied to seizure-free rate• 100% resection gave 100% seizure-free postop course in two-thirds (8 of 12)

• Compared to open approach• Shorter LOS endoscopic

• 4.5 versus 7.7 days

• Comparable seizure-free rates• 49 % vs. 54 % (endo vs. TC)

• Tumors smaller in endoscopic• 1.01 vs 2.43 cc (p=0.0322)

• Reasons to favor open approach• Larger tumors (>1.5 cm) with bilateral attachments

• Better for children younger than adolescent age

• 6 mm of space needed between top of tumor and roof of 3rd for endoscope

Page 16: Symposium for Patients  & Caregivers

Seizure control

Abla et al., AANS Philadelphia. May 3, 2010

Page 17: Symposium for Patients  & Caregivers

Outcome

• Seizure freedom: 29-49%• Seizure Reduction: 55-73%• In older patients, higher IQ correlated with better

chance of seizure freedom• Memory loss 8% permanent• Adults had more complications than children

Page 18: Symposium for Patients  & Caregivers

Complications

• Postoperative DI• Usually transient (< 1 week). DDAVP given in ICU

• Weight gain (satiety center = VMH)• 19% in open TC

• Short-term memory loss• Transient

• 58 % in TC group / 14 % in endoscopic group (< 2 wks)

• Permanent• ~ 8 % in both (2/26 and 3/37)Ng, Rekate et al. Epilepsia 2006

Page 19: Symposium for Patients  & Caregivers

SMALL LARGE

Type I OZ OZ

Gamma Knife (stable)

Type II Endoscopic Transcallosal

Gamma Knife (bilateral, clinically stable)

Type III Endoscopic +/- OZ ---

Gamma Knife (stable)

Type IV --- Staged : target main component 1st

BNI Treatment Paradigm

Page 20: Symposium for Patients  & Caregivers

Conclusions

• PROPER SELECTION

• No single approach is appropriate or advantageous for all patients

• Decisions individualized• Surgical anatomy• Presence of acute clinical deterioration

Page 21: Symposium for Patients  & Caregivers

A Special Thanks To Our Sponsors• Aesculap

• Barrow Neurological Institute @ St. Joseph’s Hospital

• Barrow Neurological Institute @ Phoenix Children’s Hospital

• Great Council for the Improved

• Hope for Hypothalamic Hamartoma Foundation

• KARL STORZ Endoskope